Skip to main content
. 2017 Aug 21;114(36):E7441–E7449. doi: 10.1073/pnas.1705013114

Fig. S2.

Fig. S2.

Confocal microscopic images of DLBCL and B6 mice. (A) Images of lymph node histological sections from DLBCL mice. The first row shows a PAPR1-stained section from a DLBCL mouse injected with PARPi-FL. The second row shows a PARP1-stained lymph node section from a mouse preblocked with olaparib. The third row shows a nonspecific antibody-stained control for PARP1. The fourth row shows the nonspecific signal of the secondary fluorescent antibodies without primary antibodies for PARP1. (B) Representative image of an immunostaining slide from the spleen of a DLBCL mouse injected with PARPi-FL. (C) Representative images from slides of lymph node and spleen from a B6 mouse injected with PARPi-FL.